Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Barone

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy peopleSonia Garritano, Chiara De Santi, Roberto Silvestri, et al.
Oncotarget|January 7, 2016
Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeAlessio Naccarati, Fabio Rosa, Veronika Vymetalkova, et al.
Archives of Toxicology|January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinomaLucia Pellé, Monica Cipollini, Roman Tremmel, et al.
International Journal of Molecular Sciences|July 15, 2020
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Genes & Cancer|April 25, 2017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell linesOmbretta Melaiu, Calogerina Catalano, Chiara De Santi, et al.
Occupational and Environmental Medicine|March 27, 2017
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individualsChiara De Santi, Perla Pucci, Alessandra Bonotti, et al.
Vaccines|May 28, 2022
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver DiseasesMaria De Santis, Francesca Motta, Natasa Isailovic, et al.
DNA Repair|April 11, 2016
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinomaMonica Cipollini, Gisella Figlioli, Giuseppe Maccari, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy peopleSonia Garritano, Chiara De Santi, Roberto Silvestri, et al.
Oncotarget|January 7, 2016
Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeAlessio Naccarati, Fabio Rosa, Veronika Vymetalkova, et al.
Archives of Toxicology|January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinomaLucia Pellé, Monica Cipollini, Roman Tremmel, et al.
International Journal of Molecular Sciences|July 15, 2020
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Genes & Cancer|April 25, 2017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell linesOmbretta Melaiu, Calogerina Catalano, Chiara De Santi, et al.
Occupational and Environmental Medicine|March 27, 2017
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individualsChiara De Santi, Perla Pucci, Alessandra Bonotti, et al.
Vaccines|May 28, 2022
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver DiseasesMaria De Santis, Francesca Motta, Natasa Isailovic, et al.
DNA Repair|April 11, 2016
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinomaMonica Cipollini, Gisella Figlioli, Giuseppe Maccari, et al.
Pageof 2